![]() |
|
October 18, 2009 to October 24, 2009 (Week 42) |
Posted 2009-10-30
Summary of FluWatch Findings for the
Week ending October 24, 2009
A total of 1,779 hospitalized cases including 351 (19.7%) cases admitted to ICU and 185 (10.4%) cases required ventilation as well as 92 deaths of Pandemic (H1N1) 2009 were reported to PHAC as of October 24, 2009. The proportion of females affected, the median age and the proportion of cases with underlying medical conditions was still increasing with severity of illness this week (see Characteristics table). While women and men had similar hospitalization rates, more females were admitted to ICU, required ventilation and died compared to men (approximatively 60% females vs. 40% for males for all these outcomes). As well, for those with severe outcomes, females had more underlying medical conditions than males; 74.5% vs. 70.4% of ICU admissions and 83.3% vs. 74.1% of deaths. In the Canadian population, there are more females than males in older age groups which may partially explain the differences observed.
The national crude hospitalization rate was 5.3 per 100,000 population with the highest rates in children under 15 years of age (12.1 per 100,000). The national crude mortality rate was 0.28 per 100,000 population; those 45 years and older had the highest mortality rate (0.40 per 100,000). ICU admission rate and ventilation rate were also elevated in children under one year of age (3.6 and 3.0 per 100,000, respectively).
There were 93 (26.6%) hospitalized pregnant women out of 350 hospitalized women between 15 and 44 years of age for whom the information on pregnancy was available. The median age among all pregnant cases was 28 years (range 16 to 42 years). Information on pregnancy trimester was available for 44 hospitalized women: 33 (75%) of these 44 pregnant women were in their third trimester and one woman was in postpartum. Pregnant women, who represent 1% of the population in a given year, are presenting with a higher burden of morbidity and mortality: 5% of hospitalized cases and 4% of deaths occurred among pregnant women. However, hospitalized pregnant women were admitted to ICU less frequently (18.3% vs. 29.2%), required ventilation less frequently (5.4% vs. 15.2%) and had less underlying medical conditions (33.3% vs. 57.2%) compared to hospitalized non-pregnant women between 15 and 44 years of age. The main underlying medical conditions reported by hospitalized pregnant women were pulmonary disease (including asthma) (11) and diabetes (5). Four pregnant cases resulted in death and three of these women were in their third trimester (the trimester was unknown for one case).
| Province/Territory | This week (Oct. 18-24, 2009)* | From
August 30, 2009 to October 24, 2009** |
First wave (up to August 29, 2009)** |
||||||
|---|---|---|---|---|---|---|---|---|---|
| Hospitalized cases | ICU admissions | Deaths | Hospitalized cases | ICU admissions | Deaths | Hospitalized cases | ICU admissions | Deaths | |
| BC | 88 | 21 | 3 | 145 | 30 | 7 | 54 | 21 | 5 |
| AB | 44 | 7 | 4 | 53 | 9 | 4 | 130 | 30 | 8 |
| SK | 0 | 0 | 0 | 1 | 0 | 1 | 23 | 12 | 4 |
| MB | 0 | 0 | 0 | 0 | 0 | 0 | 227 | 43 | 7 |
| ON | 32 | 8 | 2 | 65 | 13 | 4 | 374 | 67 | 23 |
| QC | 2 | 1 | 0 | 13 | 2 | 1 | 574 | 104 | 26 |
| NB | 1 | 1 | 0 | 1 | 1 | 0 | 2 | 1 | 0 |
| NS | 0 | 0 | 0 | 0 | 0 | 0 | 17 | 8 | 1 |
| PE | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 0 | 0 |
| NL | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 1 | 0 |
| YT | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| NT | 8 | 1 | 0 | 21 | 3 | 0 | 9 | 0 | 0 |
| NU | 0 | 0 | 0 | 0 | 0 | 0 | 66 | 6 | 1 |
| Canada | 175 | 39 | 9 | 299 | 58 | 17 | 1480 | 293 | 75 |
| *Based on reporting date. ** Based on epidemiological date. |
|||||||||
| 1 Proportion of cases with at least one underlying medical condition (excluding pregnancy) among those for whom the information was available. Note that P/T are now reporting on three additional underlying medical conditions : chronic liver disease, chronic neurological disease and anemia or hemoglobinopathy. 2 Percent of pregnant women among women 15 to 44 years of age. |
||||
| Hospitalizated cases (n=1,779) | Cases admitted to ICU (n=351) | Deaths (n=92) | ||
|---|---|---|---|---|
| Females, % | 51.8 | 56.4 | 60.9 | |
| Median age | 24.0 | 37.5 | 50.0 | |
| Aboriginal status, % | 16.5 | 13.4 | 10.9 | |
| Underlying medical conditions1, % | 61.9 (735/1,187) | 72.7 (181/249) | 79.7(55/69) | |
| Pregnancy2, % | 26.6 (93/350) | 19.3 (16/83) | 23.5 (4/17) | |
Striking increases in overall influenza activity were reported this week. All indicators (proportion of positive influenza tests, national ILI consultation rate, number of regions reporting widespread activity and number of influenza outbreaks) were considerably higher this week compared to the previous weeks.
Ten regions reported widespread activity in BC, SK, NL & NT and fourteen regions in BC, AB, SK, ON, QC, NB & NS reported localized activity, while twenty-three regions reported sporadic activity in MB, ON, QC, NB, PEI, NS, NL, YK & NU and seven regions in NB, NS & NL reported no activity. The 226 influenza outbreaks reported this week were all in schools except 6 in hospitals (ON, NL), 3 in long-term care facility (BC, QC) and 3 in an unspecified location (AB, ON). The schools outbreaks were in BC (100), AB (87), NT (16), SK (4), NS (4), NL (2) and NB (1). Note that this is the first year that all the provinces and territories are reporting on influenza outbreaks in schools (greater than 10% absenteeism on any day most likely due to ILI) which is increasing considerably the total number of outbreaks reported compared to the previous years.
![]() |
|
Note: Influenza activity levels, as represented on this map, are assigned and reported by Provincial and Territorial Ministries of Health, based on laboratory confirmations, sentinel ILI rates (see graphs and tables) and reported outbreaks. Please refer to detailed definitions on the last page. For areas where no data is reported, late reports from these provinces and territories will appear on the FluWatch website.

![]()
† sub-regions within the province or territory as defined by the provincial/territorial epidemiologist. Graph may change as late returns come in.

![]()
ILI consultation rate
This week, the national ILI consultation rate was 59 consultations per 1,000 patient visits (see ILI graph) which is higher compared to the previous weeks and still above the expected range for this time of the year. Four provinces (ON, NL, YK & NT) had higher ILI consultation rates than the national level this week. People under 20 years of age had the highest consultations rates with 131 and 150 per 1,000 patient visits among children under 5 years of age and among those 5 and 19 years of age, respectively.

![]()
Note: No data available for mean rate in previous years for weeks 19 to 39 (1996-1997 through 2002-2003 seasons).
*Delays in the reporting of data may cause data to change restrospectively.
Paediatric Influenza Hospitalizations and deaths
In week 42, 48 laboratory-confirmed influenza-associated paediatric hospitalizations were reported through the Immunization Monitoring Program Active (IMPACT) network. 18 hospitalizations reported this week were due to unsubtyped influenza A and 30 Pandemic (H1N1) 2009. 472 hospitalizations had been reported since week 17 (April 26); 89.8% of these hospitalizations were due to Pandemic (H1N1) 2009. Since the beginning of the pandemic, four deaths due to Pandemic (H1N1) 2009 had been reported through the IMPACT network among children under 16 years of age.
Laboratory Surveillance Summary
This week, the proportion of tests that were positive for influenza was 29.0% which is a significant increase compared to the previous weeks (see Tests table). All provinces and territories had a high proportion of positive tests for influenza this week, especially British Columbia with more than 52% of positive tests for influenza. This week, a total of 3,962 specimens tested positive for influenza this week (all A) and 99.7% of the positive influenza A subtyped specimens were Pandemic (H1N1) 2009.

![]()

![]()
| Specimens from NT, YT, and NU are sent to reference laboratories in other provinces. Note: Cumulative data includes updates to previous weeks; due to reporting delays, the sum of weekly report totals do not add up to cumulative totals. * Not subtyped |
||||||||||||
| Reporting provinces | Weekly (Oct. 18-24, 2009) | Cumulative (Aug. 30-Oct. 24, 2009) | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Influenza A | B | Influenza A | B | |||||||||
| A Total | A(H1) | A(H3) | Pand (H1N1) | A (NS)* | Total | A Total | A(H1) | A(H3) | Pand (H1N1) | A (NS)* | Total | |
| BC | 1176 | 0 | 0 | 1170 | 6 | 0 | 2648 | 0 | 0 | 2091 | 557 | 0 |
| AB | 1212 | 0 | 0 | 538 | 674 | 0 | 1847 | 0 | 0 | 769 | 1078 | 0 |
| SK | 127 | 0 | 0 | 92 | 35 | 0 | 213 | 0 | 1 | 162 | 50 | 0 |
| MB | 21 | 0 | 0 | 19 | 2 | 0 | 40 | 0 | 0 | 34 | 6 | 0 |
| ON | 818 | 0 | 0 | 467 | 351 | 0 | 1280 | 1 | 0 | 724 | 555 | 2 |
| QC | 457 | 0 | 8 | 449 | 0 | 0 | 676 | 34 | 9 | 566 | 67 | 0 |
| NB | 8 | 1 | 0 | 7 | 0 | 0 | 13 | 1 | 1 | 9 | 2 | 1 |
| NS | 67 | 0 | 0 | 63 | 4 | 0 | 87 | 0 | 0 | 77 | 10 | 0 |
| PE | 7 | 0 | 0 | 6 | 1 | 0 | 12 | 0 | 0 | 11 | 1 | 0 |
| NL | 69 | 0 | 0 | 69 | 0 | 0 | 77 | 0 | 0 | 77 | 0 | 0 |
| Canada | 3962 | 1 | 8 | 2880 | 1073 | 0 | 6893 | 36 | 11 | 4520 | 2326 | 3 |
During week 42, compared to other prescriptions filled in Canada, the sale of AV suggested continued increases in most provinces and territories. The most pronounced increases were among children (between 2 and 17 years of age) and in the province of Ontario and Western Newfoundland and Labrador.

Reference: H1N1 Antiviral and OTC Surveillance Weekly Report. CFEZID, PHAC.
Antigenic Characterization
Since September 1, 2009, NML has antigenically characterized 52 Pandemic (H1N1) 2009 viruses and two seasonal influenza viruses (one influenza A/H1N1 and one B virus) that were received from Canadian laboratories. All 52 Pandemic influenza A (H1N1) viruses characterized were antigenically related to A/California/7/2009, which is the pandemic reference virus selected by WHO as Pandemic (H1N1) 2009 vaccine. The one seasonal influenza A/H1N1 virus characterized was related to A/Brisbane/59/07, which is the influenza A/H1N1 component recommended for the 2009-10 influenza vaccine. The one influenza B virus characterized was antigenically related to B/Brisbane/60/08, which is the recommended influenza B component for the 2009-10 influenza vaccine.
Antiviral Resistance
NML: 39 Pandemic (H1N1) 2009 viruses tested so far have been sensitive to zanamivir but resistant to amantadine. 35 Pandemic (H1N1) 2009 viruses were sensitive to oseltamivir and one virus was resistant to oseltamivir with the H275Y mutation. The resistance was associated with oseltamivir treatment.
Provinces: Three cases of oseltamivir resistant Pandemic (H1N1) 2009 were reported to date in Canada from the province of Quebec on July 21, 2009, from Alberta on September 15, 2009 and from Ontario on October 13, 2009.
Vaccination
All the provinces and territories have started their vaccination campaigns except Nunavut that will start as of November 1, 2009.
Global information
Northern Hemisphere
Southern Hemisphere
| Country | No. Pandemic (H1N1) deaths | Estimated population | Mortality rate per 100, 000 |
|---|---|---|---|
| Australia | 185 | 22,025,795 | 0.84 |
| New Zealand | 19 | 4,315,800 | 0.44 |
| Mexico | 328 | 111,211,789 | 0.29 |
| UK | 119 | 61,383,000 | 0.19 |
| * Note that these cumulative crude mortality rates are estimates. | |||
FluWatch reports include data and information from five main sources: laboratory reports of positive influenza tests in Canada; sentinel physician reporting of influenza-like illness (ILI); provincial/territorial assessment of influenza activity based on various indicators, including laboratory surveillance, ILI reporting, school and work site absenteeism, and outbreaks; influenza-associated pediatric hospitalizations; WHO and other international reports of influenza activity.
The map shows influenza activity in the “influenza surveillance regions” † within each jurisdiction, as determined by the provincial/territorial epidemiologists.
Abbreviations: Newfoundland/Labrador (NL), Prince Edward Island (PE), New Brunswick (NB), Nova Scotia (NS), Quebec (QC), Ontario (ON), Manitoba (MB), Saskatchewan (SK), Alberta (AB), British Columbia (BC), Yukon (YT), Northwest Territories (NT), Nunavut (NU).
To share this page just click on the social network icon of your choice.